Comparison of PAM50 Risk of Recurrence Score With Onco<i>type</i> DX and IHC4 for Predicting Risk of Distant Recurrence After Endocrine Therapy
2013 · Journal of Clinical Oncology · 632 citations
https://doi.org/10.1200/jco.2012.46.1558
I
Ivana Šestak
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
195
Papers
11.4K
Citations
42
h-index
68
i10-index
Ivana Šestak is an academic researcher. The author has contributed to research in topics: Breast Cancer Treatment Studies & Estrogen and related hormone effects & Advanced Breast Cancer Therapies. The author has an h-index of 42, co-authored 166 publications.
ORCID: 0000-0001-6999-2851Papers by this author
worksAnastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial
2013 · The Lancet · 578 citations
https://doi.org/10.1016/s0140-6736(13)62292-8
Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial
2010 · The Lancet Oncology · 564 citations
https://doi.org/10.1016/s1470-2045(10)70266-7
Development and verification of the PAM50-based Prosigna breast cancer gene signature assay
2015 · BMC Medical Genomics · 547 citations
https://doi.org/10.1186/s12920-015-0129-6
Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial
2019 · The Lancet · 220 citations
https://doi.org/10.1016/s0140-6736(19)32955-1
Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy
2016 · JNCI Journal of the National Cancer Institute · 208 citations
https://doi.org/10.1093/jnci/djw149
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat